Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Amortization - Intangibles (2016 - 2025)

Integra Lifesciences Holdings' Amortization - Intangibles history spans 17 years, with the latest figure at $3.8 million for Q4 2025.

  • For Q4 2025, Amortization - Intangibles rose 1.4% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $15.0 million, down 29.76%, while the annual FY2025 figure was $15.0 million, 29.76% down from the prior year.
  • Amortization - Intangibles for Q4 2025 was $3.8 million at Integra Lifesciences Holdings, up from $3.7 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $10.1 million in Q1 2024 and bottomed at $3.0 million in Q2 2023.
  • The 5-year median for Amortization - Intangibles is $3.7 million (2024), against an average of $4.0 million.
  • The largest annual shift saw Amortization - Intangibles surged 225.19% in 2024 before it crashed 63.35% in 2025.
  • A 5-year view of Amortization - Intangibles shows it stood at $4.1 million in 2021, then decreased by 13.08% to $3.5 million in 2022, then dropped by 14.37% to $3.0 million in 2023, then rose by 22.48% to $3.7 million in 2024, then increased by 1.4% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for IART's Amortization - Intangibles are $3.8 million (Q4 2025), $3.7 million (Q3 2025), and $3.8 million (Q2 2025).